Tamoxifen therapy in advanced/recurrent endometrial carcinoma

Gynecologic Oncology
M A Quinn, J J Campbell

Abstract

Forty-nine patients with advanced/recurrent endometrial carcinoma were treated with Tamoxifen, 20 mg, twice daily. There were six complete and four partial responses (response rate = 20%). The median survival of responders was 34 months compared to 6 months in nonresponders. Toxicity was minimal.

References

Jul 12, 1979·The New England Journal of Medicine·K D SwenertonD A Boyes
Jun 1, 1984·European Journal of Obstetrics, Gynecology, and Reproductive Biology·G M RendinaP Nazzicone
Apr 1, 1981·Gynecologic Oncology·J BonteP Wynants

Citations

Jun 1, 2006·Current Opinion in Obstetrics & Gynecology·Beth W Rackow, Aydin Arici
Jun 1, 1994·British Journal of Obstetrics and Gynaecology·C H LaiY K Soong
Apr 20, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S B Decruze, J A Green
Dec 1, 1991·Statistics in Medicine·D G Altman
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S GibbonsG Malkasian
Feb 18, 2016·Expert Opinion on Investigational Drugs·Marco Johannes Battista, Marcus Schmidt
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J SchneiderM Volm
Jan 5, 2002·Obstetrics and Gynecology Clinics of North America·E Hernandez
Apr 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·W R Miller, S P Langdon
Jun 23, 2016·The British Journal of Radiology·Chong Hyun SuhAtul B Shinagare
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Fani KokkaAndrew Bryant
Jul 13, 2002·Expert Review of Anticancer Therapy·Mark Baekelandt
Aug 30, 2005·Molecular Human Reproduction·M Kabir-SalmaniM Iwashita
Jul 10, 2009·Expert Opinion on Pharmacotherapy·Nicanor I Barrena MedelThomas J Herzog
May 28, 2019·Frontiers in Oncology·Willem Jan van WeeldenAndrea Romano
Feb 24, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·A Gadducci, A R Genazzani

Related Concepts

Carcinoma, Cribriform
Carcinoma, Papillary
Squamous Cell Carcinoma
Drug Evaluation
Neoplasm Recurrence, Local
Zitazonium
Uterine Cancer

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.